Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute myeloid leukemia”
CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT04493164. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib in Combination With Venetoclax and Azacitidine for the Treatment of Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06454409. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
ClinicalTrials.gov study NCT06317649. IPD Sharing: YES. Countries: 2. Publications: 0.
Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05000801. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Microtransplantation in Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02831192. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Decitabine, Donor Natural Killer Cells, and Aldesleukin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02316964. IPD Sharing: NO. Countries: 1. Publications: 0.
Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma
ClinicalTrials.gov study NCT00003885. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Elesclomol Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01280786. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02390635. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Investigator-initiated Clinical Trial (Phase II) of Cancer Vaccine "Dainippon Sumitomo Phama(DSP)-7888" for Acute Myeloid Leukemia Patients.
ClinicalTrials.gov study NCT04747002. IPD Sharing: NO. Countries: 1. Publications: 0.
CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase
ClinicalTrials.gov study NCT00084916. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Maintenance Therapy With Histamine Dihydrochloride and Interleukin-2 in Adult Acute Myeloid Leukemia (AML) Patients With Measurable Minimal Residual Disease (MRD)- a Non-interventional Study (NIS)
ClinicalTrials.gov study NCT01770158. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dasatinib Combined With Chemotherapy in Relapsed t(8;21) Acute Myeloid Leukemia With KIT D816 Mutation
ClinicalTrials.gov study NCT03560908. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of CBX-250 in Participants With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
ClinicalTrials.gov study NCT06994676. IPD Sharing: YES. Countries: 1. Publications: 0.
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic M
ClinicalTrials.gov study NCT04375631. IPD Sharing: NO. Countries: 1. Publications: 0.
Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00027872. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03484520. IPD Sharing: NO. Countries: 3. Publications: 0.
Decitabine+Cladribine+Cytarabine+Granulocyte Colony-stimulating Factor (D-CLAG) for Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04373395. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Natural Killer Cells Infusion for Treating Acute Myeloid Leukemia Patients With Minimal Residual Disease
ClinicalTrials.gov study NCT04209712. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Dosage Individualisation for the Treatment of Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00969891. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.